Mark L. Jacobson Axsome Therapeutics, Inc. (AXSM) insider trading activity

Mark L. Jacobson is Chief Operating Officer of Axsome Therapeutics, Inc.. Currently has a direct ownership of 0 shares of AXSM, which is worth approximately $0. The most recent transaction as insider was on Sep 22, 2025, when has been sold 10,000 shares (Common Stock) at a price of $115.96 per share, resulting in proceeds of $1,159,600. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

100.0% 12M change

Total Value Held $0

Mark L. Jacobson Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 22 2025	SELL Open market or private sale	$1,159,600 $115.96 p/Share	10,000 Reduced 100.0%	0 Common Stock
Sep 22 2025	BUY Exercise of conversion of derivative security	$28,500 $2.85 p/Share	10,000 Added 50.0%	10,000 Common Stock
Sep 16 2025	SELL Open market or private sale	$5,274,659 $115.21 p/Share	45,783 Reduced 100.0%	0 Common Stock
Sep 16 2025	BUY Exercise of conversion of derivative security	$196,000 $4.9 p/Share	40,000 Added 50.0%	40,000 Common Stock
Jun 09 2025	SELL Open market or private sale	$2,761,000 $110.44 p/Share	25,000 Reduced 81.21%	5,783 Common Stock
Jun 09 2025	BUY Exercise of conversion of derivative security	$200,500 $8.02 p/Share	25,000 Added 44.82%	30,783 Common Stock
May 28 2025	SELL Open market or private sale	$2,069,000 $103.45 p/Share	20,000 Reduced 77.57%	5,783 Common Stock

May 28 2025	BUY Exercise of conversion of derivative security	$129,400 $6.47 p/Share	20,000 Added 43.68%	25,783 Common Stock
May 27 2025	SELL Open market or private sale	$2,163,636 $104.66 p/Share	20,673 Reduced 78.14%	5,783 Common Stock
May 27 2025	BUY Exercise of conversion of derivative security	$133,754 $6.47 p/Share	20,673 Added 43.86%	26,456 Common Stock
Aug 09 2024	SELL Open market or private sale	$4,022,488 $84.26 p/Share	47,739 Reduced 89.2%	5,783 Common Stock
Aug 09 2024	BUY Exercise of conversion of derivative security	$192,865 $4.04 p/Share	47,739 Added 47.14%	53,522 Common Stock
May 29 2024	SELL Open market or private sale	$587,792 $74.31 p/Share	7,910 Reduced 57.77%	5,783 Common Stock
May 29 2024	BUY Exercise of conversion of derivative security	$17,800 $1.3 p/Share	13,693 Added 50.0%	13,693 Common Stock
Apr 01 2024	SELL Open market or private sale	$1,904,892 $77.24 p/Share	24,662 Reduced 100.0%	0 Common Stock
Apr 01 2024	BUY Exercise of conversion of derivative security	$32,060 $1.3 p/Share	24,662 Added 50.0%	24,662 Common Stock

MLJ

Mark L. Jacobson

Chief Operating Officer

New York, NY

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AXSM shares.

Notify only if

Value

Insider Trading

Get notified when an Axsome Therapeutics, Inc. insider buys or sells AXSM shares.

Notify only if

Operation

Value

Type

News

Receive news related to Axsome Therapeutics, Inc.

Track Activities on AXSM

Account